Cynata Therapeutics Limited (ASX:CYP) Requests Trading Halt
Cynata Therapeutics Limited (ASX:CYP) has announced a trading halt pending a significant clinical trial update.
COSOL Limited (ASX:COS) Expands Data Analytics with Toustone Acquisition
COSOL Limited enhances its data analytics capabilities with the acquisition of Toustone, aiming for growth in enterprise asset analytics.
Acrux Limited (ASX:ACR) Receives FDA Approval for Nitroglycerin Ointment
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Pro Medicus Limited (ASX:PME) Co-Founders Sell Shares
Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall sell shares, reaffirming their commitment and retaining significant holdings.
Lycaon Resources Ltd (ASX:LYN) Commences Maiden Drill Program
Lycaon Resources Ltd launches maiden drilling at Stansmore, aiming for major mineral discoveries supported by government funding.
EQ Resources Ltd (ASX:EQR) Revises Funding Strategy for Expansion
EQ Resources Ltd revises its funding strategy, opting out of the QIC loan for the Mt Carbine mine expansion while securing alternative funding arrangements.
Xamble Group Limited (ASX:XGL) Reports Q3 2024 Business Update
Xamble Group Limited reports a strategic restructuring, closure of unprofitable operations, and positive outlook in Q3 2024 update.
Blackstone Minerals Limited (ASX: BSX) Completes Entitlement Offer
Blackstone Minerals Limited completes its Entitlement Offer, securing significant funding for future growth initiatives.
Qube Holdings Limited (ASX:QUB) Prices $600 Million Senior Unsecured Notes
Qube Holdings Limited has priced $600 million in senior unsecured notes, aiming to enhance liquidity and diversify its funding sources.
Black Dragon Gold (ASX:BDG) Faces Setback at Salave Project
Black Dragon Gold faces permitting delays as its land re-zoning application for the Salave Gold Project is rejected by local council.